Profile

    Corporate information


    Registration country
    Investment activity status
    Active investor

    Company type

    A biotechnology company, develops medicines to treat cancer and fibrotic diseases

    Funding rounds

    Acquisition USD 225,000,000


    USD 225,000,000 (20 Dec 2010) at USD 225,000,000 valuation.

    Profile Country Notes
    Gilead Sciences Inc A biopharmaceutical company that discovers, develops and commercializes therapeutics. United States


    Profile Country Notes
    Duff Ackerman & Goodrich Ventures A mid-stage venture capital partnership with a service-oriented mindset. United States
    Healthcare Ventures LLC Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. United States
    Kleiner Perkins Caufield & Byers LLC Venture capital firm. United States
    Northgate Capital United States

    Current and past shareholders

    Investor Contacts Round
    Duff Ackerman & Goodrich Ventures logo Duff Ackerman & Goodrich Ventures
    A mid-stage venture capital partnership with a service-oriented mindset.
    +1 (415) 788-2755
    N/A
    Gilead Sciences Inc logo Gilead Sciences Inc
    A biopharmaceutical company that discovers, develops and commercializes therapeutics.
    Acquisition
    Healthcare Ventures LLC logo Healthcare Ventures LLC
    Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage.
    +1 (617) 252-4343
    N/A
    Kleiner Perkins Caufield & Byers LLC logo Kleiner Perkins Caufield & Byers LLC
    Venture capital firm.
    +1 (650) 233-2750
    N/A
    Northgate Capital logo Northgate Capital
    N/A